Partnerships & Alliances
Filter News
Found 38,661 articles
-
Brii Biosciences is launching to accelerate the development and delivery of breakthrough drugs in China with $260 million in financial backing.
-
San Diego-based Bloom Science launched to develop epilepsy treatments based on a new class of neuroprotective drugs. The company, whose research was published in the journal Cell today, focuses on gut bacteria involved in the anti-seizure effects of the ketogenic diet.
-
Novo Nordisk licensed an experimental chronic kidney disease (CKD) and diabetic kidney disease (DKD) treatment in a deal that could be worth up to $200 million for San Diego-based Epigen Biosciences.
-
The University of Chicago’s Polsky Center is designed to set business students who have a mind to become entrepreneurs with scientists hoping to turn their research into a beneficial product.
-
San Diego-based Epigen Biosciences enters a collaboration to license its LPA1 Receptor small molecule program to Novo Nordisk A/S for up to USD 200 Million
5/24/2018
Epigen Biosciences, Inc. announced today that it has entered into a collaboration agreement with Novo Nordisk...
-
QPharma Expands KOL Presence in Europe
5/24/2018
Titanium® Technology to Perform Influence Mapping in 15 European Countries
-
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
5/24/2018
New programs added in respiratory and cardio-metabolic diseases
-
Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics’ Product, Leukine®
5/24/2018
Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc. (PTx), an integrated biopharmaceutical company.
-
Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck
5/24/2018
Pan-Cancer MSI Companion Diagnostic for KEYTRUDA® (pembrolizumab) Planned for Inclusion on FoundationOne CDx™
-
Cara Therapeutics Grabs $70 Million Upfront in Licensing Deal for Late-Stage Kidney Disease Drug
5/23/2018
Shares of Cara Therapeutics are soaring this morning after the company announced it secured $70 million in cash as part of a licensing agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. (VFMCRP) for the company’s chronic kidney disease treatment Korsuva. -
Astero Bio Acquires Key Technologies for the Management of Cryopreserved Biologics from BroadOak Capital Partners
5/23/2018
In conjunction with the acquisition, Astero will receive growth capital investment from BroadOak.
-
Altasciences Establishes Strategic Alliance with Altreos Research Partners
5/23/2018
Vince & Associates Clinical Research, an Altasciences company, announced today their strategic alliance with Altreos Research Partners.
-
CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease
5/23/2018
Centogene, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced a clinical development collaboration with Orphazyme A/S.
-
mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States
5/23/2018
The agreement to bring a biosimilar of bevacizumab to the United States will improve patient access and affordability of this important oncology treatment.
-
Clinigen and Mitsubishi Tanabe initiate European Managed Access Program for edaravone to treat ALS
5/23/2018
Clinigen Group plc has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’), to initiate a Managed Access Program (also known as an Early Access Program) in Europe for edaravone, an intravenous treatment for amyotrophic lateral sclerosis (‘ALS’).
-
Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease
5/23/2018
Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrop.
-
OncoDNA announces screening collaboration with Kura Oncology
5/23/2018
OncoDNA is pleased to announce that it has signed a screening agreement with Kura Oncology, Inc.
-
Berkeley Lights and TPG Biologics Enter into a Strategic Collaboration for Cell Line Development
5/23/2018
Program Implements Beacon Platform for Creating Workflow Efficiencies to Accelerate the Drug Development Process
-
Sun Pharma Announces USFDA Approval of YONSA® (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone
5/23/2018
Sun Pharmaceutical Industries Ltd. and Churchill Pharmaceuticals, LLC. today announced that one of Sun Pharma’s wholly owned subsidiary companies has received approval from the U.S. Food and Drug Administration (FDA) for YONSA® (abiraterone acetate).
-
Celgene Corporation and Evotec AG announced they have inked a long-term strategic partnership to find and develop new cancer drugs.The partnership will lean on Evotec’s preclinical discovery and development platforms.